Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2026-02-27 @ 3:13 AM
Study NCT ID:
NCT03754803
Status:
COMPLETED
Last Update Posted:
2025-08-17
First Post:
2018-10-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany
Sponsor:
ViiV Healthcare
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
208983
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |